These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33614584)

  • 1. Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing
    Adar A; Zayyad H; Azrad M; Libai K; Aharon I; Nitzan O; Peretz A
    Front Public Health; 2021; 9():616793. PubMed ID: 33614584
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.
    Hoellinger B; Deboscker S; Danion F; Lavigne T; Severac F; Ruch Y; Ursenbach A; Lefebvre N; Boyer P; Hansmann Y
    Microbiol Spectr; 2022 Dec; 10(6):e0186822. PubMed ID: 36321906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.
    Wielders CCH; Schouls LM; Woudt SHS; Notermans DW; Hendrickx APA; Bakker J; Kuijper EJ; Schoffelen AF; de Greeff SC; ;
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):57. PubMed ID: 35397546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing Enterobacterales.
    Assis R; Lasnoy M; Adler A
    J Glob Antimicrob Resist; 2021 Sep; 26():108-113. PubMed ID: 34118482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
    Park JW; Lee H; Park SY; Kim TH
    Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART).
    Jean SS; Hsueh PR;
    J Glob Antimicrob Resist; 2020 Jun; 21():91-98. PubMed ID: 31627023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Hovan MR; Narayanan N; Cedarbaum V; Bhowmick T; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115505. PubMed ID: 34399381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.
    Adler A; Hussein O; Ben-David D; Masarwa S; Navon-Venezia S; Schwaber MJ; Carmeli Y;
    J Antimicrob Chemother; 2015 Jan; 70(1):89-92. PubMed ID: 25204343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia with Carbapenemase-Producing
    Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J
    Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.